Clinical trial sites are burdened by pass-through costs, which are not fully reimbursed, leading to financial strain. The process of invoicing for these costs is time-consuming and often results in delayed or unreceived payments, causing additional administrative and financing expenses for the site. This impacts the site's operations, staff resources, and overall financial well-being.